Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

16.9K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
16.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional Genomics Screening in <i>Chlamydomonas reinhardtii</i> Maps the Genetic Landscape of Tolerance to Paraquat and Diuron.

Environmental science & technology·2026
Same author

CDK4/6 Inhibitors for Breast Cancer Therapy-A Review of Clinical Trials, Structural and Computational Approaches.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

The rise of bispecific antibodies for dual targeting, singular impact: technology and clinical advancements.

International immunopharmacology·2026
Same author

pH-Responsive peptide nanopores are stabilized by lipid and water-mediated hydrogen bonding networks.

Nanoscale·2026
Same author

Small-molecule inhibitors of 6-phosphofructo-1-kinase simultaneously suppress lactate and superoxide generation in cancer cells.

PloS one·2025
Same author

Unveiling polyphenol-protein interactions: a comprehensive computational analysis.

Journal of cheminformatics·2025

Related Experiment Video

Updated: Dec 22, 2025

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
06:53

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells

Published on: June 2, 2022

3.5K

Loop Grafting between Similar Local Environments for Fc-Silent Antibodies.

Samo Lešnik1, Milan Hodošček1, Barbara Podobnik2

  • 1National Institute of Chemistry, Hajdrihova 19, SI-1000 Ljubljana, Slovenia.

Journal of Chemical Information and Modeling
|May 8, 2020
PubMed
Summary

Fc-silencing reduces antibody effector functions but can cause instability. Loop grafting offers a novel method to reduce antibody binding to immune receptors while maintaining stability, avoiding common issues with traditional Fc-silencing techniques.

More Related Videos

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations
09:07

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

Published on: August 22, 2019

11.3K
Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

19.2K

Related Experiment Videos

Last Updated: Dec 22, 2025

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
06:53

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells

Published on: June 2, 2022

3.5K
Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations
09:07

Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations

Published on: August 22, 2019

11.3K
Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

19.2K

Area of Science:

  • Biochemistry
  • Immunology
  • Structural Biology

Background:

  • Fc-silencing by amino acid substitution reduces antibody effector functions but may cause instability and immunogenicity.
  • Monoclonal antibody therapeutics rely on Fc-receptor interactions for efficacy, but modulating these interactions is crucial for safety.

Purpose of the Study:

  • To evaluate loop grafting as a novel Fc-silencing strategy for antibody therapeutics.
  • To assess the impact of loop grafting on Fc region binding affinity, stability, and immunogenicity compared to standard Fc-silencing methods.

Main Methods:

  • Designed Fc variants using loop grafting, replacing Fc loops with segments from similar antibody environments.
  • Employed molecular dynamics simulations to analyze Fc region-FcγIIIa complex interactions.
  • Compared loop-grafted variants with standard Fc-silenced variants (less than eight amino acid substitutions).

Main Results:

  • Loop grafting significantly reduced antibody binding to FcγIIIa while maintaining Fc region stability.
  • Standard Fc-silencing variants exhibited potential instability and reduced Fc-silencing efficacy due to compensatory interactions.
  • Molecular dynamics simulations confirmed the efficacy of loop grafting in modulating Fc receptor binding.

Conclusions:

  • Loop grafting is a promising, generalizable approach for Fc-silencing in antibody therapeutics.
  • This method effectively reduces immune effector functions without compromising antibody stability or increasing immunogenicity.
  • Loop grafting offers an alternative to traditional Fc-silencing, overcoming limitations of instability and immunogenicity.